PharmaCorp Rx (TSXV:PCRX) - Stock Price, News & Analysis

PCRX Stock Overview

Operates retail pharmacies under the PharmaChoice name in Canada.

PCRX fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	5/6
Dividends	0/6

Rewards

Risk Analysis

Makes less than USD$1m in revenue (CA$291K)

Shareholders have been substantially diluted in the past year

Volatile share price over the past 3 months compared to the Canadian market

Does not have a meaningful market cap (CA$81M)

PharmaCorp Rx Inc. Competitors

CareRx

TSX:CRRX

CA$126.2m

Neighbourly Pharmacy

TSX:NBLY

CA$840.4m

Ceres Global Ag

TSX:CRP

CA$98.3m

Sucro

TSXV:SUGR

CA$60.0m

Price History & Performance

Summary of all time highs, changes and price drops for PharmaCorp Rx
Historical stock prices
Current Share Price	CA$0.69
52 Week High	CA$0.88
52 Week Low	CA$0.43
Beta	-6.35
11 Month Change	-1.43%
3 Month Change	n/a
1 Year Change	n/a
33 Year Change	n/a
5 Year Change	n/a
Change since IPO	475.00%

Recent updates

Shareholder Returns

	PCRX	CA Consumer Retailing	CA Market
7D	0%	-2.0%	0.6%
1Y	n/a	21.5%	23.3%

Return vs Industry: Insufficient data to determine how PCRX performed against the Canadian Consumer Retailing industry.

Return vs Market: Insufficient data to determine how PCRX performed against the Canadian Market.

Price Volatility

Is PCRX's price volatile compared to industry and market?
PCRX volatility
PCRX Average Weekly Movement	16.1%
Consumer Retailing Industry Average Movement	3.2%
Market Average Movement	8.2%
10% most volatile stocks in CA Market	17.1%
10% least volatile stocks in CA Market	3.1%

Stable Share Price: PCRX's share price has been volatile over the past 3 months compared to the Canadian market.

Volatility Over Time: Insufficient data to determine PCRX's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2021	n/a	Grady Brown	n/a

PharmaCorp Rx Inc. operates retail pharmacies under the PharmaChoice name in Canada. It offers prescription drug and custom compounding specialization services; weight loss and lifestyle management solutions, including health and wellness products; vitamins and supplements; and convenience and confectionary products. The company was incorporated in 2021 and is based in Saskatoon, Canada.

PharmaCorp Rx Inc. Fundamentals Summary

How do PharmaCorp Rx's earnings and revenue compare to its market cap?
PCRX fundamental statistics
Market cap	CA$80.70m
Earnings (TTM)	-CA$1.12m
Revenue (TTM)	CA$291.42k

276.9x

P/S Ratio

-72.4x

P/E Ratio

Is PCRX overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PCRX income statement (TTM)
Revenue	CA$291.42k
Cost of Revenue	CA$192.75k
Gross Profit	CA$98.66k
Other Expenses	CA$1.21m
Earnings	-CA$1.12m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	-0.0095
Gross Margin	33.86%
Net Profit Margin	-382.71%
Debt/Equity Ratio	1.9%

How did PCRX perform over the long term?

See historical performance and comparison

PharmaCorp Rx TSXV:PCRX Stock Report